The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Transarterial chemoembolization (TACE) combined with camrelizumab and apatinib versus TACE alone in the treatment of unresectable hepatocellular carcinoma eligible for embolization: A multicenter, open-label, randomized, phase 2 study (CAP-ACE).
 
Haidong Zhu
No Relationships to Disclose
 
Gao-Jun Teng
No Relationships to Disclose
 
Weijun Fan
No Relationships to Disclose
 
Jian-Song Ji
No Relationships to Disclose
 
Wei-Zhu Yang
No Relationships to Disclose
 
Chang Zhao
No Relationships to Disclose
 
Ming Huang
No Relationships to Disclose
 
Song Wang
No Relationships to Disclose
 
Yu-Liang Li
No Relationships to Disclose
 
Guo-Liang Shao
No Relationships to Disclose
 
Hong-Tao Cheng
No Relationships to Disclose
 
Yong-Yi Zeng
No Relationships to Disclose
 
Weifu Lv
No Relationships to Disclose
 
Hao Xu
No Relationships to Disclose
 
Ligong Lu
No Relationships to Disclose
 
Hai-Bo Shao
No Relationships to Disclose
 
Xu-Ya Zhao
No Relationships to Disclose
 
Shanzhi Gu
No Relationships to Disclose
 
Hai-Lan Lin
No Relationships to Disclose
 
Wen-Heng Zheng
No Relationships to Disclose